tiprankstipranks
Trending News
More News >
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
US Market

Caris Life Sciences, Inc. (CAI) Income Statement

Compare
135 Followers

Caris Life Sciences, Inc. Income Statement

Last quarter (Q4 2025), Caris Life Sciences, Inc.'s total revenue was $292.89M, an increase of 190.48% from the same quarter last year. In Q4, Caris Life Sciences, Inc.'s net income was $81.96M. See Caris Life Sciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 20
Total Revenue
$ 812.03M$ 412.26M$ 306.13M$ 258.49M$ 294.01M
Gross Profit
$ 539.17M$ 178.78M$ 89.31M$ 80.02M$ 184.16M
Operating Expenses
$ 494.06M$ 435.90M$ 408.86M$ 395.78M$ 45.07M
Depreciation and Amortization
$ 22.61M$ 48.91M$ 49.00M$ 48.25M$ 110.65M
EBITDA
$ 11.38M$ -182.95M$ -260.80M$ -245.89M$ 254.46M
Operating Income
$ 45.11M$ -257.12M$ -319.55M$ -315.76M$ 139.09M
Other Income/Expenses
$ -113.20M$ -24.77M$ -21.86M$ -5.07M$ -109.55M
Pretax Income
$ -68.09M$ -281.89M$ -341.42M$ -320.83M$ 29.53M
Net Income
$ -537.96M$ -281.89M$ -341.42M$ -320.83M$ 27.73M
Per Share Metrics
Basic EPS
$ -1.90$ -2.70$ -1.82$ -1.57$ 1.55
Diluted EPS
$ -1.90$ -2.70$ -1.82$ -1.57$ 1.55
Weighted Average Shares Outstanding
1.67B 254.66M 254.66M 254.79M 17.95M
Weighted Average Shares Outstanding (Diluted)
1.67B 254.66M 254.66M 254.79M 17.95M
Currency in USD

Caris Life Sciences, Inc. Earnings and Revenue History